CGEM
Cullinan Oncology LLC
NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY
$12.85
+0.31% today
Updated 2026-04-29
Market cap
$837.68M
P/E ratio
—
P/S ratio
25.86x
EPS (TTM)
$-3.36
Dividend yield
—
52W range
$6 – $17
Volume
0.8M
Cullinan Oncology LLC (CGEM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $-718406.00 | $-91716.00 | $-24030.00 | $-228911.00 | $-13.55M | $-20.90M | $-29.77M | $-43.43M | $-126.66M | $-134.28M | $-145.30M | $-175.75M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $261000.00 | $20000.00 | $10000.00 | $589225.00 | $1.13M | $208000.00 | $0.00 | $49000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $17000.00 | $14.91M | $24.38M | $27.96M | $30.44M | $37.82M | $36.04M |
| Free cash flow | — | $-718406.00 | $-91716.00 | $-24030.00 | $-228911.00 | $-13.81M | $-20.92M | $-29.78M | $-44.02M | $-127.80M | $-134.48M | $-145.30M | $-175.80M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | $-108.42M | $96.38M | — | — | — |